gms | German Medical Science

67th Annual Meeting of the German Society of Neurosurgery (DGNC)
Joint Meeting with the Korean Neurosurgical Society (KNS)

German Society of Neurosurgery (DGNC)

12 - 15 June 2016, Frankfurt am Main

Decompressive hemicraniectomy (DHC) for malignant cerebral infarction: Any change in the perioperative risk profile after systemic, local or mechanical recanalization treatment?

Meeting Abstract

  • Walid Albanna - Neurochirurgische Klinik, Universitätsklinikum der RWTH Aachen, Germany
  • Mohamed Alzaiyani - Neurochirurgische Klinik, Universitätsklinikum der RWTH Aachen, Germany
  • Marc Brockmann - Klinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum der RWTH Aachen, Germany
  • Hans Clusmann - Neurochirurgische Klinik, Universitätsklinikum der RWTH Aachen, Germany
  • Johannes Schiefer - Neurologische Klinik, Universitätsklinikum der RWTH Aachen, Germany
  • Gerrit Schubert - Neurochirurgische Klinik, Universitätsklinikum der RWTH Aachen, Germany

Deutsche Gesellschaft für Neurochirurgie. 67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 1. Joint Meeting mit der Koreanischen Gesellschaft für Neurochirurgie (KNS). Frankfurt am Main, 12.-15.06.2016. Düsseldorf: German Medical Science GMS Publishing House; 2016. DocDI.11.03

doi: 10.3205/16dgnc161, urn:nbn:de:0183-16dgnc1614

Published: June 8, 2016

© 2016 Albanna et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: New data advocates early mechanical recanalization in addition to intravenous or intraarterial lysis for acute, intracranial large vessel occlusion. For those few cases still requiring decompressive hemicraniectomy (DHC) for impending malignant cerebral infarction thereafter, the influence of presurgial recanalization treatment (lysis and/or thrombectomy) on the perioperative complication rate is unclear and is therefore the purpose of this study.

Method: A total of 82 patients (age 52.6 ± 10.3yrs) with complete clinical data sets undergoing DHC for malignant cerebral infarction between 2005 and 2015 were included for this retrospective analysis. With comparable demographic data (age, sex, GCS and NIHSS at admission), the following outcome parameters were analyzed after dichotomization for DHC with or without pre-surgical treatment (IV lysis, IA lysis, thrombectomy or combination of treatments): duration of surgery, intraoperative blood loss, transfusion requirement, any postoperative hemorrhage (any intracranial or subgaleal hyperdensity on postop CT), need for revision surgery and overall outcome (GOS) after three months.

Results: A total of 40 patients (48.8%) received pre-surgical treatment such as IV lysis, IA lysis, thrombectomy or a combination of treatments. When compared to patients without preceding treatment, there was no statistically significant difference in the need for preoperative reversal of coagulopathy or anticoagulation (52.5% vs 35.7%, ns), duration of surgery (101 ± 42mins vs 97.4 ± 37.2mins, ns), intraoperative blood loss (311 ± 120.4ml vs 341.9 ± 123.9ml, ns), intraoperative transfusion requirement (15% vs 23.8%, ns), postoperative hemorrhage (10% vs 11.9%, ns) or any need for revision surgery (12.5% vs 11.9%, ns). The rate of favourable outcome (GOS 4-5) after three months was also comparable (39.4% vs 24.2%, ns). A subgroup analysis showed that only patients receiving a combination of treatments (thrombectomy, and intraarterial and intravenous lysis) had a higher incidence of any hyperdensity in postop CT imaging (n=6, 66.7%, p<0.01).

Conclusions: Presurgical recanalization (lysis or thrombectomy) does not negatively affect the perioperative risk profile of decompressive hemicraniectomy for impending malignant stroke. Future studies will have to reevaluate and substantiate indications for DHC in view of the efficacy of recanalization, but this will not be limited by anticipated alterations in the surgical risk profile.